avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ebf3
|
ENSMUSG00000010476.7 | early B cell factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ebf3 | mm10_v2_chr7_-_137314394_137314445 | 0.27 | 1.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 22.7 | GO:0030221 | basophil differentiation(GO:0030221) |
3.4 | 10.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
3.0 | 12.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.8 | 22.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.5 | 19.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.3 | 13.8 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.9 | 9.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.7 | 5.1 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
1.7 | 5.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) neuron projection maintenance(GO:1990535) |
1.5 | 6.2 | GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
1.4 | 4.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.2 | 5.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.1 | 2.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.1 | 4.4 | GO:0061743 | motor learning(GO:0061743) |
1.1 | 3.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.1 | 9.7 | GO:0002432 | granuloma formation(GO:0002432) |
1.1 | 4.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
1.0 | 4.0 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
1.0 | 2.9 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.8 | 3.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.8 | 4.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 22.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.8 | 4.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 23.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.8 | 4.5 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.6 | 1.3 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.6 | 6.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 3.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.6 | 2.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.6 | 0.6 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.6 | 3.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 3.8 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.5 | 1.6 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.5 | 2.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.5 | 2.6 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 4.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 3.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 2.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 4.7 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.5 | 1.4 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.5 | 2.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.4 | 2.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 1.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) positive regulation of sperm motility(GO:1902093) |
0.4 | 1.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 7.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 2.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.4 | 3.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 2.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.9 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.4 | 1.1 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.4 | 1.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.3 | 1.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.7 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.3 | 6.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 5.8 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 3.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 0.6 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
0.3 | 2.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.3 | 4.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 4.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 5.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 0.6 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
0.3 | 5.6 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 4.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 1.4 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.3 | 2.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 1.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 1.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 2.9 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 2.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 1.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 10.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 2.4 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 1.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 1.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 15.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.7 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 10.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 9.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 2.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 8.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 5.7 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 3.5 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 1.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 2.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 3.9 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 3.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 14.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 5.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 3.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 6.6 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 3.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.8 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 2.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 3.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 2.4 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 3.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 1.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 1.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 3.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 1.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 8.3 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 1.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 1.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 5.2 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
0.1 | 2.8 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 1.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 1.3 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 4.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 4.4 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 2.4 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 3.8 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 1.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 5.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.0 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.7 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.1 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.0 | 4.9 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.0 | 6.2 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.4 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.8 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.0 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 3.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.6 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.9 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 1.5 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 1.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 2.0 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.4 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.0 | 18.5 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 7.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 3.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.9 | 4.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.9 | 4.4 | GO:0044301 | climbing fiber(GO:0044301) |
0.9 | 9.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 3.3 | GO:0044393 | microspike(GO:0044393) Schwann cell microvillus(GO:0097454) |
0.7 | 4.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.7 | 3.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.6 | 8.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 3.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.6 | 2.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.5 | 3.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 4.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 1.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 5.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 8.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 1.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 1.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 5.2 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.3 | 3.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.3 | 11.4 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 3.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 4.0 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 22.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 2.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 5.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 22.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 17.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 3.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 4.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 2.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 3.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 3.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 4.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 3.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 2.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 5.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.3 | GO:0071564 | SWI/SNF complex(GO:0016514) npBAF complex(GO:0071564) |
0.1 | 15.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 4.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.9 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 1.1 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 6.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 2.7 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 6.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 18.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 9.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 6.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 4.3 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 1.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 2.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 1.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 2.8 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 5.8 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 16.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.3 | 9.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
2.3 | 6.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
2.1 | 6.2 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.7 | 11.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.6 | 15.6 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 12.0 | GO:0033691 | sialic acid binding(GO:0033691) |
1.3 | 21.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.2 | 6.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.2 | 5.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.2 | 5.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.1 | 6.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.1 | 22.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.1 | 3.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
1.0 | 4.0 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.9 | 4.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.9 | 4.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.8 | 25.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 2.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.7 | 2.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.7 | 3.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.7 | 4.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.7 | 2.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.6 | 5.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.6 | 4.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 3.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 6.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 1.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.4 | 1.6 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 3.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 2.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 3.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 4.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 15.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 3.8 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 3.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 4.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 3.4 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 3.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 1.4 | GO:0015100 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.3 | 9.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 17.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 2.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 0.8 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.3 | 4.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.7 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 2.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 5.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 13.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 3.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 5.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 5.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 4.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.2 | 2.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 2.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 9.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 2.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 3.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 4.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 2.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 4.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 3.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 15.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 2.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 10.1 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 3.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 10.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 5.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 2.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 1.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 2.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 2.7 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 3.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 20.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 2.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 2.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 2.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 1.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 3.0 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 1.0 | GO:0005178 | integrin binding(GO:0005178) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 17.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 3.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 26.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 12.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 32.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 1.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 7.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 3.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 11.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 4.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 8.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 3.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 2.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 12.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 3.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 3.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 6.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 4.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 13.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 33.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.5 | 19.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 20.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 11.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 9.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 15.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 4.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 6.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 6.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 4.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 28.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 7.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 26.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 4.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 6.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 6.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 11.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 3.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 9.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 2.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 3.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.9 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 2.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 3.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 2.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 1.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 1.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 4.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 3.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |